Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Neurology

Understanding Your Child's Diagnosis: An Introduction to Sturge-Weber Syndrome

At a Glance

Sturge-Weber syndrome is a rare, noninherited condition caused by a random GNAQ change during early development. It can affect the skin, brain, and eyes, so children need symptom-based monitoring by a coordinated team that may include neurology, ophthalmology, dermatology, and pediatrics.

Receiving a diagnosis of Sturge-Weber syndrome (SWS) can feel overwhelming and life-altering. It is natural to feel a range of emotions, from confusion to deep concern for your child’s future. Please know that you are not alone, and this diagnosis is not the result of anything you did or did not do [1].

Sturge-Weber syndrome is a rare condition, occurring in approximately 1 out of every 20,000 to 50,000 live births [2]. It is a neurocutaneous disorder, meaning it primarily affects the brain (neuro) and the skin (cutaneous), along with the eyes [3]. Understanding the biology and the “triad” of symptoms can help you navigate the first steps of your child’s care.

The Cause: Somatic Mosaicism

One of the most important things for parents to understand is that SWS is not inherited. You did not pass a “bad gene” to your child, and it is highly unlikely to happen again in future pregnancies [1]. Genetic testing usually cannot predict an individual child’s severity or future course, and a genetics counselor can help address any family planning or recurrence concerns.

The condition is caused by a somatic mutation, specifically a variant in a gene called GNAQ [4]. Unlike inherited mutations that are present in every cell of the body from the moment of conception, a somatic mutation happens randomly in a single cell during early embryonic development [5].

  • Mosaicism: Because the mutation happens after development has already started, only the cells that descend from that one original mutated cell will carry the SWS variant. This is called mosaicism—your child’s body is a “mosaic” of healthy cells and cells with the mutation [5].
  • Location Matters: Where the mutation ends up determines which parts of the body are affected. This explains why some children have a birthmark on their face, while others have involvement in their brain or eyes, or a combination of all three [6].

The Three Clinical Types (Roach Scale)

Doctors sometimes use a tool called the Roach Scale to classify SWS based on which parts of the “triad” (skin, brain, and eyes) are involved [3]. It is important to know that these categories are descriptive labels; they do not by themselves predict severity, development, or future eye and neurologic needs.

Type Description
Type I The most common form. It involves both a facial birthmark and brain involvement (leptomeningeal angiomatosis). Glaucoma may also be present [3].
Type II Involves a facial birthmark and potentially glaucoma, but there is no evidence of brain involvement on current imaging [7].
Type III Involves the brain but has no facial birthmark and typically no eye involvement. This type is often the hardest to diagnose because there are no outward signs on the skin [8].

The “Triad” of Symptoms

While every child is different, SWS is defined by three main areas of involvement:

1. Facial Port-Wine Birthmark

This is a capillary malformation, a collection of small, dilated blood vessels near the surface of the skin [6]. It is usually present at birth and typically appears on the forehead or upper eyelid [9]. While it is a visible marker, the size of the birthmark does not always predict the severity of brain or eye involvement [10].

2. Brain Involvement (Leptomeningeal Angiomatosis)

This refers to an abnormal growth of blood vessels on the surface of the brain, most often on the same side as the facial birthmark [3]. These vessels can affect blood flow, potentially leading to:

  • Seizures: Often the first neurologic sign, occurring in many children with brain involvement [10].
  • Stroke-like episodes: Weakness or vision changes that can mimic a stroke [10].
  • Developmental delays: Some children may face challenges with learning or motor skills [11].

3. Eye Involvement (Glaucoma)

Increased pressure within the eye, known as glaucoma, is common in SWS. It can be present at birth or develop years later [12]. If left untreated, high eye pressure can damage the optic nerve and lead to vision loss. Children with birthmarks involving the eyelids are at the highest risk [13].

Building a Care Team

Because SWS affects different systems, your child will need a multidisciplinary care team—a group of specialists who work together to monitor their health [14].

  • Neurologist: To monitor brain health, manage seizures, and track development [9].
  • Ophthalmologist: To perform regular eye exams and check for signs of glaucoma [9][12].
  • Dermatologist: To evaluate the port-wine birthmark and discuss laser treatments if appropriate [14].
  • Pediatrician: To coordinate overall care and ensure your child hits their developmental milestones [14].

Early diagnosis and regular monitoring are the most powerful tools you have. While an MRI can help confirm brain involvement, timing depends on your child’s symptoms. A child with seizures or focal weakness should not wait for a particular age for an MRI. Conversely, early scans in asymptomatic infants can sometimes miss subtle changes and be falsely negative [15][3]. A “Type II” classification or normal early scan does not permanently rule out brain involvement, and surveillance is based on your child’s actual symptoms and ongoing examinations.

Common questions in this guide

What causes Sturge-Weber syndrome, and did I pass it to my child?
Sturge-Weber syndrome results from a random change in the GNAQ gene that occurs in some cells during early development. It is not inherited from a parent, and the chance of it happening again in a future pregnancy is very low. A genetics counselor can discuss individual family-planning concerns.
What do the three Roach Scale types mean?
The Roach Scale describes whether Sturge-Weber syndrome involves the facial skin, brain, and eyes. Type I includes a facial birthmark and brain involvement and may also include glaucoma; Type II includes a facial birthmark with no brain involvement seen on current imaging; Type III includes brain involvement without a facial birthmark and usually without eye involvement. These labels describe the areas involved but do not by themselves predict severity or future needs.
Does my child’s port-wine birthmark mean they have brain involvement?
No. A port-wine birthmark is a skin finding, and its size does not reliably predict brain or eye involvement. Doctors consider its location together with symptoms, eye examinations, brain imaging, and ongoing follow-up.
What signs of Sturge-Weber syndrome should I watch for at home?
Watch for seizures, new weakness, vision changes, or episodes that look like a stroke. Also tell the care team about changes in learning, movement, or development. Your child’s clinician can explain specific warning signs, when to seek emergency help, and how to create a seizure action plan.
When should my child have an MRI?
MRI timing depends on your child’s symptoms and examinations. A child with seizures or focal weakness should be evaluated promptly rather than waiting for a particular age. In an infant without symptoms, an early scan can miss subtle changes, so a normal early MRI does not permanently rule out brain involvement.
Can glaucoma develop later in a child with Sturge-Weber syndrome?
Yes. Glaucoma may be present at birth or develop years later, especially when the port-wine birthmark involves an eyelid. Regular eye examinations help detect increased eye pressure before it damages the optic nerve.
Which specialists care for a child with Sturge-Weber syndrome?
Care may involve a neurologist for seizures and brain health, an ophthalmologist for glaucoma screening, a dermatologist for the birthmark, and a pediatrician to coordinate overall care and development. These clinicians may need to communicate regularly because Sturge-Weber syndrome can affect more than one body system. The exact schedule depends on symptoms and findings.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What type of Sturge-Weber syndrome (Roach Scale) does my child have, and what specific tests confirmed this?
  2. 2.Based on my child's birthmark location, what is their specific risk level for brain or eye involvement?
  3. 3.Since early MRIs can sometimes be falsely negative, what is the right timing for my child to have a brain scan based on their symptoms?
  4. 4.What signs of a seizure or a 'stroke-like episode' should I be watching for at home?
  5. 5.Can you help us create a 'Seizure Action Plan' and explain when we should call emergency services?
  6. 6.Which specialists (neurology, ophthalmology, dermatology) do we need to see, and how often will they need to coordinate my child's care?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Somatic GNAQ Mutation is Enriched in Brain Endothelial Cells in Sturge-Weber Syndrome.

    Huang L, Couto JA, Pinto A, et al.

    Pediatric neurology 2017; (67()):59-63 doi:10.1016/j.pediatrneurol.2016.10.010.

    PMID: 27919468
  2. 2

    Sturge-Weber syndrome.

    Comi AM

    Handbook of clinical neurology 2015; (132()):157-68.

    PMID: 26564078
  3. 3

    Sturge-Weber syndrome: Updates in pathogenesis, diagnosis, and treatment.

    Valery CB, Comi AM

    Annals of the Child Neurology Society 2023; (1(3)):186-201 doi:10.1002/cns3.20031.

    PMID: 42563829
  4. 4

    Endothelial GNAQ p.R183Q Increases ANGPT2 (Angiopoietin-2) and Drives Formation of Enlarged Blood Vessels.

    Huang L, Bichsel C, Norris AL, et al.

    Arteriosclerosis, thrombosis, and vascular biology 2022; (42(1)):e27-e43 doi:10.1161/ATVBAHA.121.316651.

    PMID: 34670408
  5. 5

    Developmental expression of the Sturge-Weber syndrome-associated genetic mutation in Gnaq: a formal test of Happle's paradominant inheritance hypothesis.

    Wetzel-Strong SE, Galeffi F, Benavides C, et al.

    Genetics 2023; (224(4)) doi:10.1093/genetics/iyad077.

    PMID: 37098137
  6. 6

    Sturge-Weber syndrome: an overview of history, genetics, clinical manifestations, and management.

    Ramirez EL, Jülich K

    Seminars in pediatric neurology 2024; (51()):101151 doi:10.1016/j.spen.2024.101151.

    PMID: 39389653
  7. 7

    Sturge-Weber syndrome Type I: a rare case report.

    Hendieh B, Khana F, Ibrahim S, et al.

    Annals of medicine and surgery (2012) 2025; (87(9)):6216-6220 doi:10.1097/MS9.0000000000003711.

    PMID: 40901129
  8. 8

    Isolated leptomeningeal angiomatosis in Sturge-weber syndrome type III: A case report with distinctive neuroimaging features.

    Laaraje A, Ben Elhend S

    Radiology case reports 2025; (20(5)):2487-2490 doi:10.1016/j.radcr.2025.01.092.

    PMID: 40129826
  9. 9

    Consensus Statement for the Management and Treatment of Sturge-Weber Syndrome: Neurology, Neuroimaging, and Ophthalmology Recommendations.

    Sabeti S, Ball KL, Bhattacharya SK, et al.

    Pediatric neurology 2021; (121()):59-66 doi:10.1016/j.pediatrneurol.2021.04.013.

    PMID: 34153815
  10. 10

    Sturge-Weber syndrome: an update for the pediatrician.

    Dingenen E, Segers D, De Maeseneer H, Van Gysel D

    World journal of pediatrics : WJP 2024; (20(5)):435-443 doi:10.1007/s12519-024-00809-y.

    PMID: 38658498
  11. 11

    Predictors of Cognitive Functions in Children With Sturge-Weber Syndrome: A Longitudinal Study.

    Bosnyák E, Behen ME, Guy WC, et al.

    Pediatric neurology 2016; (61()):38-45.

    PMID: 27353695
  12. 12

    Sturge-Weber Syndrome: A Review of Pathophysiology, Genetics, Clinical Features, and Current Management Approache.

    Sánchez-Espino LF, Ivars M, Antoñanzas J, Baselga E

    The application of clinical genetics 2023; (16()):63-81 doi:10.2147/TACG.S363685.

    PMID: 37124240
  13. 13

    Port-wine Birthmarks: Update on Diagnosis, Risk Assessment for Sturge-Weber Syndrome, and Management.

    Poliner A, Fernandez Faith E, Blieden L, et al.

    Pediatrics in review 2022; (43(9)):507-516 doi:10.1542/pir.2021-005437.

    PMID: 36045161
  14. 14

    Multidisciplinary, multicenter consensus for the care of patients affected with Sturge-Weber syndrome.

    El Hachem M, Diociaiuti A, Galeotti A, et al.

    Orphanet journal of rare diseases 2025; (20(1)):28 doi:10.1186/s13023-024-03527-w.

    PMID: 39819452
  15. 15

    Early magnetic resonance imaging to detect presymptomatic leptomeningeal angioma in children with suspected Sturge-Weber syndrome.

    Bar C, Pedespan JM, Boccara O, et al.

    Developmental medicine and child neurology 2020; (62(2)):227-233 doi:10.1111/dmcn.14253.

    PMID: 31050360

This page is for informational purposes only and does not constitute medical advice. Your child’s neurologist, ophthalmologist, and other clinicians can interpret symptoms and recommend an individualized care plan.

Get notified when new evidence is published on Sturge-Weber syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.